Director of differentiating technologies for the Drug Substance business at Evonik Health Care

Michael is currently director of differentiating technologies for the Drug Substance business at Evonik Health Care. He has over 17 years of experience in pharmaceutical process development, and the pharmaceutical and CMO industry. 

Michael holds a PhD in organic synthesis from the University of Heidelberg in Germany, and completed a PhD research fellowship at Texas A&M University in the U.S. He began his industry career as a laboratory head at Archimica in Frankfurt, and then transitioned through various roles in R&D and process development at Archimica’s successor companies Euticals and AMRI, as well as at Evonik Health Care, before taking on his current business role. 

Michael’s main areas of interest include catalysis, continuous processing, high potent manufacturing and the sustainable production of APIs and intermediates.